Antitumor compound targeting IDH2 mutation and method of use thereof
US-10155722-B2 · Dec 18, 2018 · US
being further substituted by carboxyl groups
being further substituted by carboxyl groups · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07C275/42 |
| Official title | being further substituted by carboxyl groups |
| Display label | being further substituted by carboxyl groups |
| Total patents | 123 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 15 |
| 2016 | 16 |
| 2017 | 19 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 13 |
| 2022 | 12 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases
US-10131637-B2 · Nov 20, 2018 · US
3-aryl propiolonitrile compounds for thiol labeling
US-10131626-B2 · Nov 20, 2018 · US
Tripodal nitrate receptor
US-10060892-B2 · Aug 28, 2018 · US
Antitumor compound targeting idh2 mutation and method of use thereof
US-2018222853-A1 · Aug 9, 2018 · US
hTRPV1 CHEMICAL AGENTS
US-2018215705-A1 · Aug 2, 2018 · US
Modulators of development of adipocyte and cancer cells
US-10029991-B2 · Jul 24, 2018 · US
6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives
US-9957261-B2 · May 1, 2018 · US
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
US-2018079712-A1 · Mar 22, 2018 · US
Use of DDX3X inhibitors for the treatment of pneumovirus infections
US-9884812-B2 · Feb 6, 2018 · US
18f-labeled triazole containing psma inhibitors
US-2017369454-A1 · Dec 28, 2017 · US
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
US-9850264-B2 · Dec 26, 2017 · US
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
US-2017320897-A1 · Nov 9, 2017 · US
IDO inhibitors
US-9790169-B2 · Oct 17, 2017 · US
IDO inhibitors
US-9765018-B2 · Sep 19, 2017 · US
IDO inhibitors
US-9758492-B2 · Sep 12, 2017 · US
Ido inhibitors
US-2017231999-A1 · Aug 17, 2017 · US
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
US-2017216326-A1 · Aug 3, 2017 · US
3-aryl propiolonitrile compounds for thiol labeling
US-2017210700-A1 · Jul 27, 2017 · US
Omega-3 analogues
US-2017183297-A1 · Jun 29, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07C275/42?
- CPC C07C275/42 is the Cooperative Patent Classification code for “being further substituted by carboxyl groups.”
- How many patents are filed under CPC C07C275/42 (being further substituted by carboxyl groups)?
- Our database includes 123 publications tagged with this CPC code.
- Is patent activity under CPC C07C275/42 growing?
- Publication counts under this code: 3 in 2024 vs 1 in 2025 (latest complete years).